National Bank of Canada’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

National Bank of Canada’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30	Closed	-$888	–	3026
2025 Q1	$888	Hold	30	–	–	﹤0.01%	2589
2024 Q4	$975	Hold	30	–	–	﹤0.01%	2650
2024 Q3	$1.21K	Hold	30	–	–	﹤0.01%	2409
2024 Q2	$1.55K	Hold	30	–	–	﹤0.01%	2449
2024 Q1	$1.25K	Hold	30	–	–	﹤0.01%	2519
2023 Q4	$1.24K	Hold	30	–	–	﹤0.01%	2518
2023 Q3	$1.48K	Hold	30	–	–	﹤0.01%	2544
2023 Q2	$1.84K	Hold	30	–	–	﹤0.01%	2481
2023 Q1	$1.35K	Hold	30	–	–	﹤0.01%	2491
2022 Q4	$3.67K	Hold	30	–	–	﹤0.01%	2389
2022 Q3	$4K	Hold	30	–	–	﹤0.01%	2371
2022 Q2	$5K	Hold	30	–	–	﹤0.01%	2416
2022 Q1	$7K	Hold	30	–	–	﹤0.01%	2462
2021 Q4	$8K	Buy	+30	New	+$8.26K	﹤0.01%	2415

Other funds holding CANF

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CAM

Costello Asset Management Feasterville, Pennsylvania $333M AUM 25.99% 1-Year Est. Return

National Bank of Canada's CANF Position: Q2 2025 in Review

National Bank of Canada sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q2 2025, closing a stake of 30 shares — an estimated $888 sold.

National Bank of Canada first reported a position in CANF in Q4 2021 and held it in 14 quarters. The position peaked at $8K in Q4 2021. 14 funds tracked by Wall St. Rank hold CANF as of Q2 2025.

National Bank of Canada reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q2 2025 after selling out during the quarter.
National Bank of Canada sold 30 Can-Fite BioPharma American Depositary Shares shares in Q2 2025, an estimated $888.
National Bank of Canada first reported a position in Can-Fite BioPharma American Depositary Shares in Q4 2021 and held it in 14 quarters.
National Bank of Canada's Can-Fite BioPharma American Depositary Shares position peaked at $8K in Q4 2021.
14 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2025.

Based on National Bank of Canada's 13F filing for Q2 2025, filed 13 Aug 2025.